UK markets closed
NIKKEI 225
38,236.07 -37.98 (-0.10%) HANG SENG
18,207.13 +444.10 (+2.50%) CRUDE OIL
79.03 +0.03 (+0.04%) GOLD FUTURES
2,311.30 +0.30 (+0.01%) DOW
38,167.69 +264.40 (+0.70%) Bitcoin GBP
47,304.02 +1,596.78 (+3.49%)
Virpax Pharmaceuticals, Inc. (VRPX)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
As of 03:50PM EDT. Market open.
| Previous close | 2.5000 |
| Open | 2.3950 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's range | 2.1050 - 2.5000 |
| 52-week range | 2.1050 - 11.7700 |
| Volume | |
| Avg. volume | 26,255 |
| Market cap | 2.524M |
| Beta (5Y monthly) | 1.38 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -12.9700 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 20.00 |
Business WireVirpax Announces Results of Maximum Tolerated Dose Study for Probudur™
BERWYN, Pa., April 30, 2024--Virpax Announces Results of MTD Study for Probudur. Liposomal Formulation Developed to Provide Both Immediate and Sustained Pain Relief
Business WireVirpax Pharmaceuticals Reports 2023 Year-End Results
BERWYN, Pa., March 26, 2024--Virpax Reports 2023 Year-End Results
Business WireVirpax Pharmaceuticals Announces Reverse Stock Split to Regain Compliance with Nasdaq’s Minimum Bid Price
BERWYN, Pa., February 27, 2024--Virpax Announces Reverse Stock Split to Regain Compliance with Nasdaq’s Minimum Bid Price
© 2024 Yahoo. All rights reserved.